Eli Lilly & Co. (LLY)
1027.51
+18.13
(+1.80%)
USD |
NYSE |
Dec 12, 16:00
1029.21
+1.70
(+0.17%)
After-Hours: 20:00
Eli Lilly Market Cap: 919.64B for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 171.10B |
| Regeneron Pharmaceuticals, Inc. | 77.91B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.191B |
| Moderna, Inc. | 11.51B |
Market Cap Related Metrics
| PE Ratio | 50.82 |
| PS Ratio | 15.77 |
| PEG Ratio | 0.4193 |
| Price to Book Value | 38.65 |
| Price to Free Cash Flow | 145.54 |
| Price | 1027.51 |
| Earnings Yield | 1.97% |
| PEGY Ratio | 0.4173 |
| Operating PE Ratio | 35.50 |
| Normalized PE Ratio | 45.51 |